• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[慢性血液透析患者的放射性核素研究。用于评估和控制肾性骨病的骨闪烁显像]

[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].

作者信息

Dudczak R, Kletter K, Czembirek H, Derfler K, Marosi L, Salomonowitz E, Schmidt P, Wurzer G, Zazgornik J

出版信息

Wien Klin Wochenschr. 1984 Apr 27;96(9):326-32.

PMID:6236616
Abstract

The clinical applicability of bone scintigraphy (Tc99m MDP) was evaluated in 42 patients on maintenance hemodialysis. Typical scintigraphic findings are shown which were related to hormonal and biochemical parameters of calcium and phosphate metabolism. Visual grading of representative regions for metabolic bone disease in bone scans was compared to scintimetry which applies a bone to soft tissue ratio to grade osseous abnormalities. It could be shown that visual interpretation and grading of the findings according to a score is sufficient to assess the degree and extent of renal bone disease. Semiquantitative analysis of bone scintigrams by scintimetry did not improve the diagnostic information.

摘要

对42例维持性血液透析患者评估了骨闪烁显像(Tc99m亚甲基二膦酸盐)的临床适用性。展示了典型的闪烁显像结果,这些结果与钙和磷代谢的激素及生化参数相关。将骨扫描中代谢性骨病代表性区域的视觉分级与应用骨与软组织比值对骨异常进行分级的骨闪烁测定法进行了比较。结果表明,根据评分对结果进行视觉解读和分级足以评估肾性骨病的程度和范围。通过骨闪烁测定法对骨闪烁图进行半定量分析并未改善诊断信息。

相似文献

1
[Radionuclide studies in chronically hemodialyzed patients. Bone scintigraphy for the evaluation and control of renal osteopathy].[慢性血液透析患者的放射性核素研究。用于评估和控制肾性骨病的骨闪烁显像]
Wien Klin Wochenschr. 1984 Apr 27;96(9):326-32.
2
[Bone scintigraphy with 99mTc-labeled methylene diphosphonate in hemodialysis patients (author's transl)].
Radioisotopes. 1981 Nov;30(11):609-11.
3
A clinical assessment of the relationship between bone scintigraphy and serum biochemical markers in hemodialysis patients.
Ann Nucl Med. 2004 Sep;18(6):513-8. doi: 10.1007/BF02984569.
4
[The value of scintimetry compared with histomorphology, parathormone assay, densitometry and radiology in renal osteopathy (author's transl)].[闪烁扫描术与组织形态学、甲状旁腺激素测定、骨密度测定及放射学在肾性骨病中的价值比较(作者译)]
Rofo. 1982 Jan;136(1):9-13. doi: 10.1055/s-2008-1055987.
5
[Classification of bone scintigrams in hemodialysis patients].
Kaku Igaku. 1985 Mar;22(3):367-76.
6
[Value of bone gammagraphy with Tc99-methyldiphosphonate (gamma G Tc99-MDP) in renal osteodystrophy].
Rev Clin Esp. 1981 Apr 25;161(1):31-5.
7
The diagnosis of renal osteodystrophy: a comparison of Technetium-99m-pyrophosphate bone scintigraphy with other techniques.
Clin Nephrol. 1981 Jul;16(1):24-8.
8
Long-term evolution of renal osteodistrophy after renal transplantation.肾移植后肾性骨营养不良的长期演变
Transplant Proc. 1989 Feb;21(1 Pt 2):2151-8.
9
Bone scintigraphy in renal osteodystrophy.
J Nucl Med. 1978 Dec;19(12):1289-96.
10
[Bone scintigraphy with 99Tcm polyphosphate in uremic osteodystrophy].
Radiol Med. 1980 Oct;66(10):760-1.